Get started
Author

Xuyong Wei

Observed names: Wei Xuyong, Wei, Xuyong, X. Wei, Xu-Yong Wei, Xuyong Wei (20103746)
Observed institutions: Zhejiang Chinese Medical University, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Westlake University, Chengdu Military General Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Zhejiang Provincial People's Hospital, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Ministry of Public Health, Hangzhou Medical College, First Affiliated Hospital Zhejiang University, Zhejiang University, Xi'an Jiaotong University
ORCID: 0000-0001-8755-5268
Observed ORCID: 0000-0001-8755-5268
OpenAlex ID: A5068560322
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
2015 · Xiao Xu, Di Lu, et al. · Gut · 276
PDF
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
2023 · Lin Tang, Sheng Pan, et al. · Molecular Therapy · 196
NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma
2011 · Jun Cheng, Hai-Yang Xie, et al. · Cancer Letters · 154
Self‐Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy
2015 · Hangxiang Wang, Haiyang Xie, et al. · Advanced Functional Materials · 138
PDF
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
2021 · Abdul Rehman Khan, Xuyong Wei, et al. · Journal of Hepatocellular Carcinoma · 111
PDF
Structure‐Based Rational Design of Prodrugs To Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy
2014 · Hangxiang Wang, Haiyang Xie, et al. · Angewandte Chemie International Edition · 96
PDF
Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c
2011 · Qi Ling, Xiao Xu, et al. · Journal of Experimental & Clinical Cancer Research · 95
PDF
Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
2022 · Linsong Tang, Rongli Wei, et al. · Computational and Structural Biotechnology Journal · 91
PDF
iRGD-Decorated Polymeric Nanoparticles for the Efficient Delivery of Vandetanib to Hepatocellular Carcinoma: Preparation and in Vitro and in Vivo Evaluation
2016 · Jianguo Wang, Hangxiang Wang, et al. · ACS Applied Materials & Interfaces · 86
Is the era of sorafenib over? A review of the literature
2020 · Guanghan Fan, Xuyong Wei, et al. · Therapeutic Advances in Medical Oncology · 85
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1
2017 · Sunbin Ling, Haiyang Xie, et al. · Journal of Hematology & Oncology · 80
PDF
RETRACTED: Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population
2012 · Qi Ling, Haiyang Xie, et al. · Journal of Hepatology · 75
Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection
2023 · Runnan Zhang, Shiqun Shao, et al. · Advanced Materials · 71
PDF
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma
2023 · Jiongjie Yu, Sunbin Ling, et al. · Journal for ImmunoTherapy of Cancer · 67
PDF
Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
2021 · Shengjun Xu, Sunbin Ling, et al. · Advanced Science · 61
PDF
Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation
2021 · Xinyu Yang, Di Lu, et al. · Cell Proliferation · 59
PDF
SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment
2023 · Shuai Wang, Rui Wang, et al. · Hepatology · 52
Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting
2018 · Li Xu, Shengjun Xu, et al. · ACS Applied Materials & Interfaces · 50
Cellular crosstalk during liver regeneration: unity in diversity
2022 · Wenzhi Shu, Mengfan Yang, et al. · Cell Communication and Signaling · 49
PDF
Chloride intracellular channel 1 participates in migration and invasion of hepatocellular carcinoma by targeting maspin
2014 · Xuyong Wei, Jie Li, et al. · Journal of Gastroenterology and Hepatology · 49
ZIP4, a Novel Determinant of Tumor Invasion in Hepatocellular Carcinoma, Contributes to Tumor Recurrence after Liver Transplantation
2014 · Xiao Xu, Hai-Jun Guo, et al. · International Journal of Biological Sciences · 47
PDF
Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer
2022 · Di Lu, Zuyuan Lin, et al. · Redox Biology · 42
PDF
The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma
2017 · Qi Ling, Xiao Xu, et al. · Oncotarget · 42
PDF
Insights into the history and tendency of liver transplantation for liver cancer: a bibliometric-based visual analysis
2023 · Xinyu He, Shengjun Xu, et al. · International Journal of Surgery · 39
Coding-noncoding gene expression in intrahepatic cholangiocarcinoma
2015 · Jianguo Wang, Haiyang Xie, et al. · Translational research · 39
Works count: 193
Citation count: 3,710
H-index: 34
I10-index: 87
Year
Topic
Type